Ranbaxy Buys Biopharma Stake

India’s largest pharmaceutical company Ranbaxy Laboratories (Gurgaon), says it has signed a definitive agreement to increase its stake in Zenotech Laboratories (Hyderabad, India) from 7%, to 45%. Zenotech develops and manufactures generic biopharmaceuticals and is a specialty generics injectable company. It also develops new biological entities in the areas of oncology and neurology. “The increasing importance of biologics in the global pharmaceutical industry and the opening up of generic biologics in the regulated markets makes it opportune for...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers